Improving Access to Affordable Health Care
It is my goal to help ensure that all Granite State families have access to affordable, quality health care. I am committed to working with the business community and all stakeholders in a fiscally responsible way to lower the skyrocketing cost of medical care. If both parties work together, we can crack down on waste, fraud, and abuse within the health care system, reduce overpayments to insurance companies, and start paying health care providers for how well they treat patients, rather than how often.
To improve access to health care for New Hampshire families, I am taking the following steps:
- Addressing the Opioid & Addiction Crisis: We are facing a public health emergency in New Hampshire with opioid and heroin addiction/overdose. That’s why I co-founded the Bipartisan Task Force to Combat the Heroin Epidemic in the last congress, and why I fought for passage of the landmark Comprehensive Addiction and Recovery Act (S.524). I also fought to include funding to address the opioid crisis in the 21st Century Cures Act (H.R.6), and I introduced Carl’s Law (H.R. 5601), which would require any medication that contains an opiate to include a warning on its label identifying the presence of opioids and the possibility of drug-seeking behavior.
- Supporting Biomedical Research: Research done by the National Institutes of Health (NIH) helps develop better tools to effectively detect, manage, and potentially cure a wide range of diseases afflicting families in New Hampshire and across the world. I recognize that this funding is critical for NIH to sustain its mission of improving health through scientific breakthroughs and maintaining international leadership in biomedical and pharmaceutical research. That is why I urged congressional leaders to approve robust funding for the NIH and its critical mission, supported making the research and development tax credit permanent, and am fighting to reverse the damaging impact of sequestration on research programs. Additionally, I supported the 21st Century Cures Act because it included billions of dollars in additional funding to innovative and groundbreaking medical technology and techniques.
- Fighting Alzheimer’s Disease: Among the top ten leading causes of death in America, Alzheimer's is the only one without a proven way to prevent it, cure it, or even slow its progression. This disease is deeply personal to me and I coauthored a book with my mother, Susan McLane, about her experience with Alzheimer's. That's why I am a proud cosponsor of the Health Outcomes, Planning, and Education (HOPE) for Alzheimer's Act (H.R. 1507), which would improve access to diagnosis of Alzheimer’s disease and related dementias, as well as to care planning services for newly diagnosed individuals and their families. As a member of the Bipartisan Congressional Taskforce on Alzheimer’s Disease, I will continue to work with my colleagues to advocate for robust funding for medical research and to increase support to Alzheimer’s patients and their caregivers. I also supported the nearly $2 billion of funding to the BRAIN Initiative found within the 21st Century Cures Act. This initiative would focus on finding cures and treatments to brain disorders, especially Alzheimer’s.
To help strengthen New Hampshire’s health care system, I am member of the Children’s Health Care Caucus, the Bipartisan Alzheimer’s Disease Task Force, the Congressional Mental Health Caucus, Congressional Military Mental Health and Suicide Prevention Caucus, and the Biomedical Research Caucus.
More on Improving Access to Affordable Health Care
Concord, NH – Today, Rep. Annie Kuster (NH-02), founder and co-chair of the Bipartisan Opioid Task Force, joined Representatives Harley Rouda (CA-48) and Ted Budd (NC-13) to introduce the bipartisan Drug-Free Communities Pandemic Relief Act. This bill would help ensure Drug-Free Communities coalitions can continue to operate and reduce youth substance use during the COVID-19 pandemic.
Concord, NH - Today, Rep. Annie Kuster (NH-02), a member of the House Energy and Commerce Health Subcommittee, issued the following statement on the U.S. Supreme Court’s ruling that weakens the Affordable Care Act’s contraceptive coverage requirement by enabling private employers to opt-out of providing contraceptive coverage for their employees.
This week, the House passed the Patient Protection and Affordable Care Enhancement Act to increase access to affordable care, lower the cost of prescription drugs, and combat racial and ethnic disparities in our health care system. The final legislation included critical provisions from Rep. Kuster’s (NH-02) bill, the Protecting Americans with Preexisting Conditions Act, to protect Americans from junk health plans.
Hopkinton, NH – Today, Rep. Annie Kuster (NH-02) participated in a virtual Energy and Commerce Committee hearing on legislative solutions to improve mental health during times of crisis. During the hearing titled, “High Anxiety and Stress: Legislation to Improve Mental Health During Crisis,” Kuster and her committee colleagues heard from Former Representative Patrick J. Kennedy, Founder of the Kennedy Forum; Dr. Arthur C. Evans, Jr., CEO of the American Psychological Association; Dr. Jeffrey L.
Concord, NH – Today, Rep. Annie Kuster (NH-02) released the following statement after the U.S. Supreme Court voted 5-4 in the case of June Medical Services v. Russo to overturn an unconstitutional Louisiana law restricting access to reproductive health care:
**As more than 120,000 Americans have died from COVID-19, Trump Administration files a brief asking the Supreme Court to strike down the entirety of crucial health care law**
**Trump lawsuit threatens access to coverage for more than 100,000 Granite Staters**
Rep. Kuster during the roundtable discussion. Watch the roundtable here.
Hopkinton, NH – On Tuesday, Rep. Annie Kuster (NH-02) participated in a virtual Energy and Commerce Committee hearing on the Trump Administration's Response to the COVID-19 Pandemic. During the hearing titled, “Oversight of the Trump Administration's Response to the COVID-19 Pandemic,” Kuster and her committee colleagues heard from Dr. Anthony Fauci, M.D., Director of the National Institute for Allergy and Infectious Diseases; ADM Brett P. Giroir, M.D., Assistant Secretary for Health, U.S.